Technical Analysis for TARA - ArTara Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -1.39% | |
| Bollinger Band Squeeze | Range Contraction | -1.39% | |
| NR7 | Range Contraction | -1.39% | |
| Narrow Range Bar | Range Contraction | -1.39% | |
| 20 DMA Resistance | Bearish | -2.41% | |
| Bollinger Band Squeeze | Range Contraction | -2.41% | |
| 20 DMA Resistance | Bearish | -2.75% |
| Alert | Time |
|---|---|
| Down 2 % | about 12 hours ago |
| 60 Minute Opening Range Breakdown | about 13 hours ago |
| Down 1% | about 13 hours ago |
| Rose Above 20 DMA | about 16 hours ago |
| 10 DMA Resistance | about 16 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
ArTara Therapeutics, Inc., a clinical-stage company, develops product candidates for patients suffering from rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. The company's lead program is TARA-002, a cellular therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. ArTara Therapeutics, Inc. is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Gastrointestinal Vitamins Chloride Lipid Liver Disease Hepatology Metabolic Disorders Choline Connective Tissue Cholinergics Treatment Of Rare Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Gastrointestinal Vitamins Chloride Lipid Liver Disease Hepatology Metabolic Disorders Choline Connective Tissue Cholinergics Treatment Of Rare Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.24 |
| 52 Week Low | 1.04 |
| Average Volume | 328,587 |
| 200-Day Moving Average | 2.41 |
| 50-Day Moving Average | 3.51 |
| 20-Day Moving Average | 2.91 |
| 10-Day Moving Average | 2.94 |
| Average True Range | 0.27 |
| RSI (14) | 39.76 |
| ADX | 25.76 |
| +DI | 20.10 |
| -DI | 12.80 |
| Chandelier Exit (Long, 3 ATRs) | 2.62 |
| Chandelier Exit (Short, 3 ATRs) | 3.43 |
| Upper Bollinger Bands | 3.15 |
| Lower Bollinger Band | 2.67 |
| Percent B (%b) | 0.34 |
| BandWidth | 16.43 |
| MACD Line | -0.16 |
| MACD Signal Line | -0.18 |
| MACD Histogram | 0.0209 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.06 | ||||
| Resistance 3 (R3) | 3.07 | 3.01 | 3.02 | ||
| Resistance 2 (R2) | 3.01 | 2.95 | 3.00 | 3.00 | |
| Resistance 1 (R1) | 2.92 | 2.92 | 2.89 | 2.91 | 2.99 |
| Pivot Point | 2.86 | 2.86 | 2.85 | 2.85 | 2.86 |
| Support 1 (S1) | 2.77 | 2.80 | 2.74 | 2.76 | 2.67 |
| Support 2 (S2) | 2.71 | 2.77 | 2.70 | 2.66 | |
| Support 3 (S3) | 2.62 | 2.71 | 2.64 | ||
| Support 4 (S4) | 2.61 |
